Role of albumin infusion (human blood protein)in liver cirrhosis

Not Applicable

• Conditions: Health Condition 1: K746- Other and unspecified cirrhosis ofliver

• Registration Number: CTRI/2019/08/020965
• Lead Sponsor: Institute of Liver and Biliary Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 24 November 2021

Recruitment & Eligibility

• Status: Open to Recruitment
• Sex: Not specified
• Target Recruitment: 0

Inclusion Criteria

1) Newly detected cirrhotic patients aged more than 18 years

2) Cirrhosis de�ned by standard clinical, analytical and/or histological criteria

3) Serum albumin level < 2.8g/dl with or without ascites

4) Who would agree to give written informed consent

Exclusion Criteria

1.Uncontrolled HTN (sys >150/ dis >90 mmHg) or h/o any drug therapy for HTN

2.Prior h/o Transjugular Intrahepatic Portosystemic Shunt (TIPS)

3.Hepatocellular Carcinoma

4.Active alcohol abuse within 3 months

5.Patients presenting as Acute on Chronic Liver Failure

6.Extrahepatic organ failure

7.Known case of chronic heart failure or respiratory failure

8.Diagnosed Chronic Kidney Disease

9.Patients with hydrothorax

10.Prior liver transplant recipient

11.Human Immunodeficiency Virus infection

12.Use of albumin infusion in the last one month

13.CTP >12, MELD >28

14.Total Bilirubin >3 g/dl

15.Overt Hepatic Encephalopathy at Presentation

Study & Design

• Study Type: Interventional
• Study Design: Not specified